CBD is short or Cannabidiol which by all scientific accounts
appears to be the ROCKSTAR of the Cannabinoid world.
It is the most predominant Cannabinoid in Hemp and is
endowed with many beneficial properties.
In its patent (#6,630,507) titled CANNABINOIDS AS
ANTIOXIDANTS AND NEUROPROTECTANTS^ the US
Government makes many impressive claims about CBD
including the following: “Cannabidiol (CBD), a
naturally-occurring constituent of the industrial hemp
plant, promotes and supports the nutritional health of
One of the properties of CBD is that it is anti-psychoactive
which means that unlike THC, the Cannabinoid found
abundantly in Marijuana, CBD is not psychoactive and may
be consumed safely as a dietary supplement.
It simply is not possible to get “high” or
intoxicated by consuming Industrial Hemp food products.
It is safe or the whole family.
THE ILLEGAL MIRACLE part 1 from Elixinol CBD Hemp Oil
How safe is MEDICAL CANNABIS?
Cannabinoids possess a remarkable safety record, particularly when compared to other therapeutically active substances, particularly prescription drugs. Most significantly, the consumption of marijuana — regardless of quantity or potency — cannot induce a fatal overdose.
What it can do to you
Investigators are also studying the anti-cancer activities of cannabis, as a growing body of preclinical and clinical data concludes that cannabinoids can reduce the spread of specific cancer cells via apoptosis (programmed cell death) and by the inhibition of angiogenesis (the formation of new blood vessels).
• Several of studies conducted by the University of California Center for Medicinal Cannabis Research assessed smoked marijuana’s ability to alleviate neuropathic pain, a notoriously difficult to treat type of nerve pain associated with cancer, diabetes, HIV/AIDS, spinal cord injury and many other debilitating conditions. Each of the trials found that cannabis consistently reduced patients’ pain levels to a degree that was as good or better than currently available medications.
• University of California Center for Medicinal Cannabis Research publicly announced the findings of a series of randomized, placebo-controlled clinical trials on the medical utility of inhaled cannabis. The studies, which utilized the so-called ‘gold standard’ FDA clinical trial design, concluded that marijuana ought to be a “first line treatment” for patients with neuropathy and other serious illnesses.
• Of particular interest, scientists are investigating cannabinoids’ capacity to moderate autoimmune disorders such as multiple sclerosis, rheumatoid arthritis, and inflammatory bowel disease, as well as their role in the treatment of neurological disorders such as Alzheimer’s disease and amyotrophic lateral sclerosis (a.k.a. Lou Gehrig’s disease.)
• In 2009, the American Medical Association (AMA) resolved “that marijuana’s status as a federal Schedule I controlled substance be reviewed with the goal of facilitating the conduct of clinical research and development of cannabinoid-based medicines.”
The scientific conclusions of the overwhelmingly majority of modern research directly conflicts with the US federal government’s stance that cannabis is a highly dangerous substance worthy of absolute criminalization.